Avacta Group (LON:AVCT) Stock Price Passes Below 200-Day Moving Average – Time to Sell?

Avacta Group Plc (LON:AVCT) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 65.35 and traded as low as GBX 64. Avacta Group shares last traded at GBX 66.20, with a volume of 5,272,169 shares.

Avacta Group Stock Up 3.7%

The firm has a 50 day simple moving average of GBX 62.99 and a two-hundred day simple moving average of GBX 65.35. The company has a quick ratio of 4.96, a current ratio of 0.79 and a debt-to-equity ratio of 14,168.75. The stock has a market capitalization of £311.33 million, a P/E ratio of -3.91 and a beta of 1.12.

Avacta Group Company Profile

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).